Biotech ETFs in focus amid deadly coronavirus outbreak

Biopharma ETFs are in focus, as various companies are working to develop vaccines to fight the deadly China virus. Exponential ETFs Founder & CEO Phil Bak joins Seana Smith on The Ticker to discuss.